FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
10,928,860
Share change
+4,167,417
Total reported value
$214,864,101
Price per share
$19.66
Number of holders
54
Value change
+$82,437,037
Number of buys
41
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2014

As of 31 Mar 2014, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,928,860 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, BVF INC/IL, ORBIMED ADVISORS LLC, TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, PUTNAM INVESTMENTS LLC, FRANKLIN RESOURCES INC, HealthCor Management, L.P., and WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST. This page lists 54 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.